560 Identification and therapeutic target of myeloid-mediated mechanisms of immunotherapy resistance in prostate cancer
Aram Lyu(Fred Hutch Cancer Center), Lawrence Fong(UCSF Helen Diller Family Comprehensive Cancer Center), Diamond Luong(University of California, San Francisco), Rachel Wolters(University of California, San Francisco), Alec Starzinski(University of California, San Francisco), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Kathryn M. Allaire(University of California, San Francisco), Kaichun Wu(Xijing Hospital), Laura Valderrábano(Broad Institute), Richard A. Miller(Collaborative Drug Discovery (United States)), Matthew D. Clark(City College of San Francisco), Zenghua Fan(University of California, San Francisco), Averey Lea(University of California, San Francisco), Marcel Arias Badia(University of California, San Francisco), Ali Setayesh(University of California, San Francisco), Vibha Gurunathan(University of California, San Francisco)
Cited by 0
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k